Table 5.
Mean health-related quality of life scores for adults patients on the TAAQoL according to type of MD
| TAAQOL | Types of MD | ||
| mean (SD) | mean (SD) | Mean (SD) | |
| LGMD2C-F | BMD | LGMD2A | |
| N = 15 | N = 25 | N = 23 | |
| Gross Motor | 36.3 (27.0) | 34.5 (27.5) | 25.3 (21.7) |
| Fine Motor | 71.7 (18.3) | 89.3 (20.0)* X | 82.9 (16.6) |
| Cognitive Functioning | 76.7 (27.1) | 83.5 (22.7) | 79.3 (31.0) |
| Sleeping | 42.5 (41.9) | 81.0 (28.7) **X | 59.8 (37.8) |
| Pain | 59.2 (34.8) | 70.8 (19.3) | 66.3 (31.9) |
| Social Functioning | 90.4 (18.0) | 93.8 (12.1) | 85.3 (22.6) |
| Daily activities | 71.3 (32.7) | 84.8 (20.6) *∇ | 57.9 (38.6) |
| Sexual functioning | 88.5 (20.1) | 95.5 (12.5) | 78.6 (39.2) |
| Vitality | 39.4 (29.3) | 61.0 (19.1) | 44.9 (31.9) |
| Happiness | 62.2 (22.9) | 72.0 (15.2) | 58.7 (23.9) |
| Aggressiveness | 78.5 (24.3) | 80.4 (21.6) | 73.4 (29.2) |
| Depressive moods | 66.1 (22.2) | 80.0 (16.7) *∇ | 60.1 (28.2) |
*p < 0.05 **p < 0.01 ***p < 0.001
∇ = BMD significantly better compared to LGMD2A;
X = BMD significantly better compared to LGMD2C-F
LGMD2C-F = Sarcoglycanopathies; BMD = Becker muscular dystrophy; LGMD2A = Calpaïnopathies